Cytomegalovirus immunoglobulin

Cytogam

2500 MG / 50 ML SolutionCanadaMarketedAuthorised 25 Apr 2000

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Cytotect CP Biotest 100 U/ml otopina za infuzijuCroatia · otopina za infuziju · Biotest Pharma GmbH, Landsteinerstr. 5, Dreieich, NjemačkaSame form
CytomegatectItaly · Soluzione per infusione · Biotest Pharma GMBHSame substance
Megalotect 100 E/ml oplossing voor infusieNetherlands · Oplossing voor infusie · Biotest Pharma GmbHSame substance
Megalotect CP Solution for Infusion 100 U/MLSingapore · 100 U/ml · injection · Grifols Asia Pacific Pte. LTD.Same substance

Documents

The official texts, at the regulator.

Register entryHealth Canada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cytomegalovirus immunoglobulin

Cytogam

2500 MG / 50 ML SolutionCanadaMarketedAuthorised 25 Apr 2000

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Register entryHealth Canada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Cytomegalovirus immunoglobulin
Strength: 2500 MG / 50 ML
Dosage form: Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 25 Apr 2000
Registration: DIN 02231962
Marketing authorisation holder: Ki Biopharma LLC
ATC code: J06BB09
Group: Anti-infectives for systemic use
Supply: SCHEDULE D